Kailera Therapeutics, Inc. (KLRA)
11.99
-0.84
(-6.55%)
USD |
NASDAQ |
Sep 21, 16:00
12.16
+0.17
(+1.42%)
After-Hours: 20:00
Kailera Therapeutics Market Cap : 1.554B for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 21, 2026 | 1.554B |
| September 18, 2026 | 1.663B |
| September 17, 2026 | 1.675B |
| September 16, 2026 | 1.646B |
| September 15, 2026 | 1.743B |
| September 14, 2026 | 1.782B |
| September 11, 2026 | 1.807B |
| September 10, 2026 | 1.933B |
| September 09, 2026 | 1.924B |
| September 08, 2026 | 2.130B |
| September 04, 2026 | 2.104B |
| September 03, 2026 | 2.040B |
| September 02, 2026 | 2.054B |
| September 01, 2026 | 2.127B |
| August 31, 2026 | 1.996B |
| August 28, 2026 | 2.101B |
| August 27, 2026 | 2.402B |
| August 26, 2026 | 2.390B |
| August 25, 2026 | 2.301B |
| August 24, 2026 | 2.144B |
| August 21, 2026 | 2.226B |
| August 20, 2026 | 2.263B |
| August 19, 2026 | 2.375B |
| August 18, 2026 | 2.311B |
| August 17, 2026 | 2.399B |
| Date | Value |
|---|---|
| August 14, 2026 | 2.325B |
| August 13, 2026 | 2.329B |
| August 12, 2026 | 2.410B |
| August 11, 2026 | 2.446B |
| August 10, 2026 | 2.460B |
| August 07, 2026 | 2.418B |
| August 06, 2026 | 2.445B |
| August 05, 2026 | 2.354B |
| August 04, 2026 | 2.346B |
| August 03, 2026 | 2.244B |
| July 31, 2026 | 2.195B |
| July 30, 2026 | 2.209B |
| July 29, 2026 | 2.187B |
| July 28, 2026 | 2.169B |
| July 27, 2026 | 2.265B |
| July 24, 2026 | 2.292B |
| July 23, 2026 | 2.254B |
| July 22, 2026 | 2.305B |
| July 21, 2026 | 2.385B |
| July 20, 2026 | 2.321B |
| July 17, 2026 | 2.403B |
| July 16, 2026 | 2.374B |
| July 15, 2026 | 2.501B |
| July 14, 2026 | 2.463B |
| July 13, 2026 | 2.587B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.709B |
| Oncolytics Biotech, Inc. | 95.51M |
| Sangamo Therapeutics, Inc. | 58.54M |
| Sarepta Therapeutics, Inc. | 2.127B |
| Anixa Biosciences, Inc. | 93.38M |
Market Cap Related Metrics
| Price to Book Value | 1.390 |
| Price | 11.99 |
| Earnings Yield | -14.10% |